Literatura académica sobre el tema "Heterologous prime-boost"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Heterologous prime-boost".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Heterologous prime-boost"
Lu, Shan. "Heterologous prime–boost vaccination". Current Opinion in Immunology 21, n.º 3 (junio de 2009): 346–51. http://dx.doi.org/10.1016/j.coi.2009.05.016.
Texto completoPan, Chien-Hsiung, Hui-mei Hu, Yu-Ju Hsiao y Sze-Hsien Wu. "Heterologous prime-boost vaccination with DNA vaccine and recombinant subunit containing four serotypes of dengue virus envelope protein domain III elicits neutralizing antibodies and specific T-cell responses (P4327)". Journal of Immunology 190, n.º 1_Supplement (1 de mayo de 2013): 123.27. http://dx.doi.org/10.4049/jimmunol.190.supp.123.27.
Texto completoTang, Xian y Zhiwei Chen. "Heterologous immunization induces potent anti-SIV immunity with qualitative and quantitative improvements (53.22)". Journal of Immunology 186, n.º 1_Supplement (1 de abril de 2011): 53.22. http://dx.doi.org/10.4049/jimmunol.186.supp.53.22.
Texto completoZHANG, G., V. T. T. HUONG, B. BATTUR, J. ZHOU, H. ZHANG, M. LIAO, O. KAWASE et al. "A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity againstToxoplasma gondiiinfection in mice". Parasitology 134, n.º 10 (17 de mayo de 2007): 1339–46. http://dx.doi.org/10.1017/s0031182007002892.
Texto completoGarg, Ishan, Abu Baker Sheikh, Suman Pal y Rahul Shekhar. "Mix-and-Match COVID-19 Vaccinations (Heterologous Boost): A Review". Infectious Disease Reports 14, n.º 4 (20 de julio de 2022): 537–46. http://dx.doi.org/10.3390/idr14040057.
Texto completoFolegatti, Pedro M., Amy Flaxman, Daniel Jenkin, Rebecca Makinson, Lucy Kingham-Page, Duncan Bellamy, Fernando Ramos Lopez et al. "Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies". Vaccines 9, n.º 3 (16 de marzo de 2021): 262. http://dx.doi.org/10.3390/vaccines9030262.
Texto completoCarlétti, Dyego, Denise Morais da Fonseca, Ana Flávia Gembre, Ana Paula Masson, Lívia Weijenborg Campos, Luciana C. C. Leite, Andréa Rodrigues Pires et al. "A Single Dose of a DNA Vaccine Encoding Apa Coencapsulated with 6,6′-Trehalose Dimycolate in Microspheres Confers Long-Term Protection against Tuberculosis in Mycobacterium bovis BCG-Primed Mice". Clinical and Vaccine Immunology 20, n.º 8 (5 de junio de 2013): 1162–69. http://dx.doi.org/10.1128/cvi.00148-13.
Texto completoDai, Ming-Shen, Ren-In You, Yu-Feng Hsieh, Kai-Yu Lo, Huey-Kang Sytwu, Georges Vassaux y Tsu-Yi Chao. "Early Treg suppression by a Listeriolysin-O-expressing E. coli vaccine in heterologous prime-boost vaccination against cancer (165.49)". Journal of Immunology 186, n.º 1_Supplement (1 de abril de 2011): 165.49. http://dx.doi.org/10.4049/jimmunol.186.supp.165.49.
Texto completoSantra, Sampa, Yue Sun, Jenny G. Parvani, Valerie Philippon, Michael S. Wyand, Kelledy Manson, Alicia Gomez-Yafal et al. "Heterologous Prime/Boost Immunization of Rhesus Monkeys by Using Diverse Poxvirus Vectors". Journal of Virology 81, n.º 16 (6 de junio de 2007): 8563–70. http://dx.doi.org/10.1128/jvi.00744-07.
Texto completoKaku, Chengzi I., Elizabeth R. Champney, Johan Normark, Marina Garcia, Carl E. Johnson, Clas Ahlm, Wanda Christ et al. "Broad anti–SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination". Science 375, n.º 6584 (4 de marzo de 2022): 1041–47. http://dx.doi.org/10.1126/science.abn2688.
Texto completoTesis sobre el tema "Heterologous prime-boost"
Badamchi-Zadeh, Alexander. "Heterologous prime-boost vaccine regimens against Chlamydia trachomatis". Thesis, Imperial College London, 2014. http://hdl.handle.net/10044/1/25021.
Texto completoLange, Uta Gisela. "Heterologous prime-boost strategies in the development of novel vaccines against leishmaniasis". Thesis, University of Cambridge, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.619876.
Texto completoPhilosof, Bar. "A bacterium from the human microbiota as a vaccine vector. Efficient priming of the murine immune system by vaginal delivery of recombinant Streptococcus gordonii". Doctoral thesis, Università di Siena, 2022. http://hdl.handle.net/11365/1216735.
Texto completoSearle, Benjamin James. "Characterisation of heterologous prime-boost vaccination strategies : an investigation into the nature and delivery of vaccines and the subsequent generation of immune responses". Thesis, University of Glasgow, 2004. http://theses.gla.ac.uk/2779/.
Texto completo"Plague vaccine: Homologous and heterologous prime-boost strategies using recombinant Yersinia pestis proteins". Tulane University, 2005.
Buscar texto completoacase@tulane.edu
Huang, Yu-Hsuan y 黃于璇. "Enhanced immune responses elicited by heterologous prime-boost vaccination using DNA/adenoviral vectors and protein of H5N1 hemagglutinin". Thesis, 2010. http://ndltd.ncl.edu.tw/handle/92699131900412448191.
Texto completo"Searching for an HIV Vaccine: A Heterologous Prime-boost System using Replicating Vaccinia Virus and Plant-produced Virus-like Particles". Doctoral diss., 2016. http://hdl.handle.net/2286/R.I.40210.
Texto completoDissertation/Thesis
Doctoral Dissertation Biological Design 2016
Capítulos de libros sobre el tema "Heterologous prime-boost"
Palmowski, Michael J. y Caroline Smith. "Heterologous Prime-Boost Vaccination in Tumor Immunotherapy". En Handbook of Cancer Vaccines, 115–20. Totowa, NJ: Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-680-5_9.
Texto completoJackson, Ronald J., David B. Boyle y Charani Ranasinghe. "Progresses in DNA-Based Heterologous Prime-Boost Immunization Strategies". En Methods in Molecular Biology, 61–90. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0410-5_5.
Texto completoMcShane, Helen, Adrian Hill y Andrew McMichael. "Overview of Heterologous Prime-Boost Immunization Strategies". En New Generation Vaccines, Fourth Edition, 396–404. CRC Press, 2009. http://dx.doi.org/10.3109/9781420060744-39.
Texto completoShnawa, Ibrahim M. S. "Heterologous Prime-boost as COVID-19 Vaccine Strategies: Towards a Nationwide Implementation". En Challenges and Advances in Pharmaceutical Research Vol. 4, 72–83. Book Publisher International (a part of SCIENCEDOMAIN International), 2022. http://dx.doi.org/10.9734/bpi/capr/v4/16535d.
Texto completoSrivastava, Indresh, Jeffrey Ulmer, Margaret Liu, Adrian Hill, Joerg Schneider y Andrew McMichael. "DNA-Modified Virus Ankara and Other Heterologous Prime-Boost Immunization Strategies for Effector T Cell Induction". En New Generation Vaccines, Fourth Edition. Informa Healthcare, 2004. http://dx.doi.org/10.1201/9781439834404.ch31.
Texto completo"DNA-Modified Virus Ankara and Other Heterologus Prime-Boost Immunization Strategies for Effector T Cell Induction". En New Generation Vaccines, 769–94. CRC Press, 2004. http://dx.doi.org/10.1201/9781439834404-38.
Texto completoActas de conferencias sobre el tema "Heterologous prime-boost"
Azevedo, Patrick, Natália Souza, Lídia Faustino, Beatriz Santos, Alexandre Machado y Ricardo Gazzinelli. "Evaluation of humoral and cellular immune response after heterologous prime-boost immunization against SARS-CoV-2". En International Symposium on Immunobiological. Instituto de Tecnologia em Imunobiológicos, 2021. http://dx.doi.org/10.35259/isi.2021_46710.
Texto completoBlair, Wade, Gijsbert Grotenbreg, Ciaran Scallan, Amy Rappaport, Renee Greer, Leonid Gitlin, Kieu Lam et al. "Abstract 724: A novel heterologous prime boost vaccine system drives tumor specific and potent CD8 T cell responses for cancer immunotherapy". En Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-724.
Texto completoKIM, SUNGBAE, KyungHae Jung, JinHee Ahn y Jeongeun Kim. "Abstract CT414: Efficient induction of cellular and humoral immune responses by heterologous prime-boost therapeutic vaccination, involving plasmid DNA and adenoviral vector, in subjects with HER2-expressing breast cancer: Results from a phase Ib study". En Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-ct414.
Texto completo